BIOVIE INC. (BIVI) earnings per share
Annual history
Fiscal years 2015 – 2025
USD / SHARE 8 PERIODS
| Period | End | Diluted | Filed |
|---|---|---|---|
| FY 2025 | 2025-06-30 | -$12.12 | 2025-08-15 |
| FY 2024 | 2024-06-30 | -$73.05 | 2024-09-30 |
| FY 2023 | 2023-06-30 | -$154.70 | 2023-08-16 |
| FY 2022 | 2022-06-30 | -$106.00 | 2022-09-27 |
| FY 2021 | 2021-06-30 | -$1482.00 | 2021-08-30 |
| FY 2020 | 2020-06-30 | -$685.00 | 2020-08-06 |
| FY 2017 | 2019-06-30 | -$98.00 | 2017-08-24 |
| FY 2015 | 2018-12-31 | -$40.00 | 2015-10-01 |
Quarterly history
Fiscal years 2015 – 2026
USD / SHARE 30 PERIODS
| Period | End | Diluted | Filed |
|---|---|---|---|
| Q3 2026 | 2026-03-31 | -$0.70 | 2026-05-11 |
| Q2 2026 | 2025-12-31 | -$0.77 | 2026-02-06 |
| Q1 2026 | 2025-09-30 | -$0.98 | 2025-11-10 |
| Q4 2025 | 2025-06-30 | -$1.44 | 2025-08-15 |
| Q3 2025 | 2025-03-31 | -$1.51 | 2025-05-12 |
| Q2 2025 | 2024-12-31 | -$4.55 | 2025-02-11 |
| Q1 2024 | 2024-09-30 | -$7.00 | 2024-11-13 |
| Q4 2024 | 2024-06-30 | -$2.65 | 2024-09-30 |
| Q3 2023 | 2024-03-31 | -$20.00 | 2024-05-14 |
| Q2 2023 | 2023-12-31 | -$22.00 | 2024-02-13 |
| Q1 2023 | 2023-09-30 | -$29.20 | 2023-11-08 |
| Q4 2023 | 2023-06-30 | -$22.70 | 2023-08-16 |
| Q3 2023 | 2023-03-31 | -$43.00 | 2023-05-12 |
| Q2 2022 | 2022-12-31 | -$50.00 | 2023-02-10 |
| Q1 2022 | 2022-09-30 | -$38.00 | 2022-11-04 |
| Q4 2022 | 2022-06-30 | -$33.00 | 2022-09-27 |
| Q3 2022 | 2022-03-31 | -$28.00 | 2022-05-11 |
| Q2 2022 | 2021-12-31 | -$22.00 | 2022-02-08 |
| Q1 2022 | 2021-09-30 | -$23.00 | 2021-11-10 |
| Q4 2021 | 2021-06-30 | -$1018.00 | 2021-08-30 |
| Q3 2021 | 2021-03-31 | -$22.00 | 2021-05-10 |
| Q2 2021 | 2020-12-31 | -$22.00 | 2021-01-29 |
| Q1 2021 | 2020-09-30 | -$775.00 | 2020-11-05 |
| Q4 2020 | 2020-06-30 | -$383.00 | 2020-08-06 |
| Q3 2020 | 2020-03-31 | -$7.00 | 2020-05-13 |
| Q2 2020 | 2019-12-31 | $129.00 | 2020-02-13 |
| Q1 2020 | 2019-09-30 | -$506.00 | 2019-11-19 |
| Q4 2017 | 2019-06-30 | -$25.00 | 2017-08-24 |
| Q3 2019 | 2019-03-31 | -$34.00 | 2019-05-10 |
| Q4 2015 | 2018-12-31 | -$20.00 | 2015-10-01 |
Methodology
Annual rows come from the filer's 10-K and Q1–Q3 rows from the matching 10-Q; Q4 is derived as full-year minus nine-month YTD because XBRL doesn't tag Q4 as its own period. EPS Basic and EPS Diluted are reported directly by the filer. Per-share values are split-adjusted to the current share count (3 split s since 2019).
For the exact XBRL concepts and formulas, see the methodology reference for EPS, FCF per share, the Q4 derivation, and split adjustment.
BIVI CIK 0001580149 Source: EDGAR filings · all facts